ロード中...
Development and Validation of a Metabolic Gene-Based Prognostic Signature for Hepatocellular Carcinoma
BACKGROUND: Hepatocellular carcinoma (HCC) is a malignant tumor with great variation in prognosis among individuals. Changes in metabolism influence disease progression and clinical outcomes. The objective of this study was to determine the overall survival (OS) risk of HCC patients from a metabolic...
保存先:
| 出版年: | J Hepatocell Carcinoma |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8018394/ https://ncbi.nlm.nih.gov/pubmed/33824863 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JHC.S300633 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|